tiprankstipranks
Anika Therapeutics (ANIK)
NASDAQ:ANIK

Anika Therapeutics (ANIK) Financial Statements

154 Followers

Anika Therapeutics Financial Overview

Anika Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.244; its P/E ratio is -5.26; Anika Therapeutics is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $0.07. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 42.97M$ 41.47M$ 44.30M$ 37.92M$ 39.62M
Gross Profit$ 26.33M$ 24.94M$ 28.97M$ 22.84M$ 24.13M
EBIT$ -1.59M$ -7.04M$ -3.07M$ -12.01M$ -6.67M
EBITDA$ 1.98M$ -2.95M$ 1.02M$ -7.92M$ -2.47M
Net Income Common Stockholders$ -63.00M$ -6.58M$ -2.74M$ 87.28M$ -4.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 108.83M$ 105.33M$ 101.81M$ 110.37M$ 120.95M
Total Assets$ 270.63M$ 328.16M$ 328.88M$ 339.07M$ 349.13M
Total Debt$ 26.90M$ 27.25M$ 27.77M$ 28.28M$ 28.82M
Net Debt$ -81.92M$ -78.08M$ -74.03M$ -82.09M$ -92.14M
Total Liabilities$ 58.37M$ 57.67M$ 54.87M$ 61.49M$ 63.56M
Stockholders Equity$ 212.26M$ 270.49M$ 274.01M$ 277.59M$ 285.56M
Cash Flow-
Free Cash Flow$ 1.80M$ 5.74M$ -9.75M$ -5.01M$ -2.05M
Operating Cash Flow$ 3.64M$ 6.49M$ -8.29M$ -3.62M$ 481.00K
Investing Cash Flow$ -1.84M$ -741.00K$ -1.46M$ -1.39M$ -2.53M
Financing Cash Flow$ 342.00K$ -110.00K$ -4.94M$ -1.61M$ 667.00K
Currency in USD

Anika Therapeutics Earnings and Revenue History

Anika Therapeutics Debt to Assets

Anika Therapeutics Cash Flow

Anika Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis